Profile data is unavailable for this security.
About the company
PHC Holdings Corp is a Japan-based company mainly engaged in the development, manufacture and sale of healthcare devices and services. The Company operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.
- Revenue in JPY (TTM)353.90bn
- Net income in JPY-12.89bn
- Incorporated2014
- Employees9.40k
- LocationPHC Holdings Corp2-38-5, Nishi-shimbashiCHIYODA-KU 100-8403JapanJPN
- Phone+81 354087280
- Websitehttps://www.phchd.com/
More ▼
Mergers & acquisitions
| Acquired company | 6523:TYO since announced | Transaction value |
|---|---|---|
| Scimed (Asia) Pte Ltd | -23.94% | -- |
Data delayed at least 20 minutes, as of May 31 2024 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao NovelBeam Technology Co Ltd | 9.55bn | 2.95bn | 113.23bn | 797.00 | 38.27 | 3.91 | -- | 11.85 | 1.12 | 1.12 | 3.62 | 10.95 | 0.3138 | 1.08 | 4.50 | 551,832.80 | 9.45 | 14.67 | 10.07 | 16.63 | 62.54 | 62.32 | 30.11 | 34.15 | 11.88 | -- | 0.0039 | 33.55 | -1.31 | 18.58 | -20.19 | 21.71 | 10.45 | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 22.18bn | 2.72bn | 118.60bn | 1.67k | 43.51 | 3.24 | -- | 5.35 | 1.11 | 1.11 | 9.07 | 14.98 | 0.5447 | 6.00 | 4.59 | 609,805.40 | 6.69 | 16.35 | 7.46 | 19.26 | 31.13 | 41.19 | 12.28 | 21.62 | 3.85 | -- | 0.0201 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
| Xiangyu Medical Co Ltd | 16.74bn | 4.94bn | 124.95bn | 1.82k | 24.84 | 2.72 | -- | 7.46 | 1.45 | 1.45 | 4.90 | 13.23 | 0.2968 | 1.08 | 18.95 | 423,724.10 | 8.80 | 11.18 | 10.79 | 13.12 | 67.66 | 66.78 | 29.64 | 32.69 | 1.89 | -- | 0.1247 | 27.33 | 52.46 | 15.72 | 81.03 | 23.11 | 132.76 | -- |
| Zhende Medical Co Ltd | 82.34bn | 2.72bn | 126.41bn | 6.72k | 46.20 | 1.06 | -- | 1.54 | 0.4728 | 0.4728 | 14.30 | 20.63 | 0.4702 | 2.96 | 5.83 | 564,307.70 | 1.74 | 17.13 | 2.16 | 23.54 | 33.65 | 38.05 | 3.71 | 17.33 | 1.88 | -- | 0.1884 | 29.85 | -32.76 | 23.63 | -70.87 | 8.79 | 21.46 | 47.58 |
| Sri Trang Gloves (Thailand) PCL | 90.40bn | 714.87m | 137.26bn | 9.40k | 191.98 | 0.8342 | 16.88 | 1.52 | 0.0583 | 0.0583 | 7.38 | 13.43 | 0.4386 | 4.74 | 9.14 | 2,248,591.00 | 0.3469 | 21.81 | 0.3841 | 24.79 | 10.30 | 39.82 | 0.7908 | 30.46 | 2.39 | -- | 0.145 | -- | -15.62 | 12.34 | -90.76 | -32.04 | -6.88 | -- |
| PHC Holdings Corp | 353.90bn | -12.89bn | 138.40bn | 9.40k | -- | 0.9901 | 9.18 | 0.3911 | -102.49 | -102.49 | 2,809.95 | 1,106.97 | 0.6287 | 3.75 | 4.95 | -- | -2.28 | -0.0766 | -3.03 | -0.1164 | 44.64 | 47.69 | -3.63 | -0.1268 | 0.9172 | 0.1158 | 0.672 | -- | -0.7109 | 13.66 | -300.16 | -- | 16.68 | -- |
| Kangji Medical Holdings Ltd | 20.14bn | 10.96bn | 147.14bn | 1.00k | 12.96 | 1.86 | 13.94 | 7.31 | 0.4646 | 0.4646 | 0.8536 | 3.24 | 0.2245 | 1.76 | 4.76 | 998,001.60 | 10.97 | 14.40 | 12.45 | 16.18 | 80.04 | 81.75 | 48.84 | 57.24 | 17.16 | -- | 0.011 | 49.58 | 17.76 | 21.23 | 5.28 | 28.00 | 41.50 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 15.68bn | 957.27m | 153.49bn | 1.09k | 164.61 | 5.00 | -- | 9.79 | 0.3189 | 0.3189 | 5.27 | 10.49 | 0.4734 | 0.8873 | 3.97 | 661,074.10 | 3.07 | 4.37 | 3.32 | 4.80 | 73.05 | 69.25 | 6.49 | 10.91 | 6.98 | -- | 0.0179 | 31.51 | 52.29 | 34.25 | 166.42 | -- | 20.42 | -- |
| Riverstone Holdings Ltd | 30.96bn | 8.22bn | 157.32bn | -- | 19.11 | 2.68 | 15.32 | 5.08 | 0.0476 | 0.0476 | 0.1794 | 0.34 | 0.478 | 6.41 | 6.69 | -- | 12.69 | 31.42 | 13.42 | 35.23 | 35.74 | 46.43 | 26.54 | 33.81 | 11.35 | 6,502.92 | 0.0005 | 65.37 | -27.37 | -0.1362 | -29.91 | 11.19 | -16.34 | 38.99 |
| LifeTech Scientific Corp | 27.56bn | 5.73bn | 157.45bn | 1.45k | 26.63 | 2.15 | 41.12 | 5.71 | 0.0635 | 0.0635 | 0.3081 | 0.7868 | 0.3022 | 0.7491 | 10.46 | 947,280.70 | 2.56 | 7.09 | 3.05 | 8.51 | 78.57 | 79.66 | 8.48 | 22.69 | 2.27 | -- | 0.1459 | 0.00 | 15.48 | 17.88 | -19.09 | 16.80 | 26.11 | -- |
Data as of May 31 2024. Currency figures normalised to PHC Holdings Corp's reporting currency: Japanese Yen JPY
5.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Global X Japan Co., Ltd.as of 10 May 2024 | 1.92m | 1.52% |
| The Vanguard Group, Inc.as of 09 May 2024 | 1.25m | 0.99% |
| Nomura Asset Management Co., Ltd.as of 30 Apr 2024 | 1.14m | 0.91% |
| Nikko Asset Management Co., Ltd.as of 10 May 2024 | 609.70k | 0.48% |
| Mellon Investments Corp.as of 09 May 2024 | 527.00k | 0.42% |
| Daiwa Asset Management Co. Ltd.as of 30 Apr 2024 | 524.50k | 0.42% |
| Healthinvest Partners ABas of 30 Jun 2022 | 440.00k | 0.35% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 309.80k | 0.25% |
| BlackRock Fund Advisorsas of 09 May 2024 | 257.30k | 0.20% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 2024 | 232.30k | 0.18% |
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
